Palisade Bio (PALI) Change in Receivables (2011 - 2023)
Palisade Bio (PALI) reported Change in Receivables of $250000.0 for Q1 2023, up 523.73% on a QoQ basis from -$59000.0 in Q3 2021.
Palisade Bio (PALI) has 12 years of Change in Receivables data on file, last reported at $250000.0 in Q1 2023.
- Quarterly Change in Receivables changed N/A year-over-year to $250000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2024 was $250000.0 (changed 0.0% YoY) and the FY2021 annual result came in at -$84000.0, down 242.37% from the prior year.
- Change in Receivables climbed to $250000.0 in Q1 2023 per PALI's latest filing, from -$59000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $250000.0 in Q1 2023 and bottomed at -$108751.0 in Q3 2019.
- The 4-year median for Change in Receivables is -$40090.0 (2019), against an average of -$4363.0.
- The widest annual swing landed in 2020, when Change in Receivables jumped 181.1%; it then tumbled 2778.05% in 2021.
- Tracing PALI's Change in Receivables over 4 years: stood at -$40090.0 in 2019, then soared by 114.97% to $6000.0 in 2020, then tumbled by 1083.33% to -$59000.0 in 2021, then jumped by 523.73% to $250000.0 in 2023.
- Per Business Quant, the three latest PALI Change in Receivables figures stand at $250000.0 (Q1 2023), -$59000.0 (Q3 2021), and $34000.0 (Q2 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 250,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Jun 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 34,000.00 |
| Mar 31, 2021 | -59,000.00 |
| Mar 31, 2021 | -59,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Jun 30, 2020 | 55,050.00 |
| Jun 30, 2020 | 55,050.00 |
| Mar 31, 2020 | -2,050.00 |
| Mar 31, 2020 | -2,050.00 |
| Dec 31, 2019 | -40,090.00 |
| Dec 31, 2019 | -40,090.00 |
| Sep 30, 2019 | -108,751.00 |
| Sep 30, 2019 | -108,751.00 |
| Jun 30, 2019 | -67,877.00 |
| Jun 30, 2019 | -67,877.00 |
| Mar 31, 2019 | -56,275.00 |
| Mar 31, 2019 | -56,275.00 |
| Dec 31, 2018 | 132,078.00 |
| Dec 31, 2018 | 132,078.00 |
| Sep 30, 2018 | -316,743.00 |
| Sep 30, 2018 | -316,743.00 |
| Jun 30, 2018 | 341,350.00 |
| Jun 30, 2018 | 341,350.00 |
| Mar 31, 2018 | -175,430.00 |
| Mar 31, 2018 | -175,430.00 |
| Dec 31, 2017 | 275,344.00 |
| Dec 31, 2017 | 275,344.00 |
| Sep 30, 2017 | 32,113.00 |
| Sep 30, 2017 | 32,113.00 |
| Jun 30, 2017 | -9,370.00 |
| Jun 30, 2017 | -9,370.00 |
| Mar 31, 2017 | 4,224.00 |
| Mar 31, 2017 | 4,224.00 |
| Dec 31, 2016 | -2,194.00 |
| Dec 31, 2016 | -2,194.00 |
| Sep 30, 2016 | 7,600.00 |
| Sep 30, 2016 | 7,600.00 |
| Jun 30, 2016 | -34,082.00 |
| Jun 30, 2016 | -34,082.00 |
| Mar 31, 2016 | 1,851.00 |
| Mar 31, 2016 | 1,851.00 |
| Dec 31, 2015 | 18,157.00 |
| Dec 31, 2015 | 18,157.00 |
| Sep 30, 2015 | 341.00 |
| Sep 30, 2015 | 341.00 |
| Jun 30, 2015 | 10,645.00 |
| Jun 30, 2015 | 10,645.00 |
| Mar 31, 2015 | -217,351.00 |
| Mar 31, 2015 | -217,351.00 |
| Dec 31, 2014 | 192,763.00 |
| Dec 31, 2014 | 192,763.00 |
| Sep 30, 2014 | 8,293.00 |
| Sep 30, 2014 | 8,293.00 |
| Jun 30, 2014 | 13,109.00 |
| Jun 30, 2014 | 13,109.00 |
| Mar 31, 2014 | 1,359.00 |
| Mar 31, 2014 | 1,359.00 |
| Dec 31, 2013 | 2,500.00 |
| Dec 31, 2013 | 2,500.00 |
| Sep 30, 2013 | -49,255.00 |
| Sep 30, 2013 | -49,255.00 |
| Jun 30, 2013 | -47,500.00 |
| Jun 30, 2013 | -47,500.00 |
| Mar 31, 2013 | 100,922.00 |
| Mar 31, 2013 | 100,922.00 |
| Dec 31, 2012 | 2,500.00 |
| Dec 31, 2012 | 2,500.00 |
| Sep 30, 2012 | -56,097.00 |
| Sep 30, 2012 | -56,097.00 |
| Jun 30, 2012 | -177,445.00 |
| Jun 30, 2012 | -177,445.00 |
| Dec 31, 2011 | 234,375.00 |
| Dec 31, 2011 | 234,375.00 |